Literature DB >> 2458823

Palliative radiotherapy for brain metastases in renal carcinoma.

M H Maor1, A E Frias, M J Oswald.   

Abstract

Between 1968 and 1985, 46 patients with renal cell carcinoma metastatic to the brain parenchyma were treated with radiation. Thirty-nine received whole-brain radiation, mostly 30 Gy in ten fractions. Symptoms improved in 30% of evaluable patients. Partial regression of metastases was documented in two of 11 available sequential computed tomographs (CT) of the brain. Seven patients were treated with surgery and postoperative radiation. In five the excision was complete and associated with clinical improvement. All 46 patients have subsequently died. The median survival time of the entire group was 8 weeks. The ten patients who improved after radiotherapy survived for a median of 17 weeks. Two additional patients were treated in 1986 with fast neutrons; both had a documented maintained complete response. Brain metastasis in renal carcinoma carries a poor prognosis. It is usually unresponsive to conventional photon therapy. In selected cases an alternative treatment with surgery or neutron therapy should be considered.

Entities:  

Mesh:

Year:  1988        PMID: 2458823     DOI: 10.1002/1097-0142(19881101)62:9<1912::aid-cncr2820620908>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

2.  High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.

Authors:  E K Seaman; S Ross; I S Sawczuk
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 3.  Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?

Authors:  Alexander Muacevic; Michael Siebels; Jörg-Christian Tonn; Berndt Wowra
Journal:  World J Urol       Date:  2005-03-25       Impact factor: 4.226

Review 4.  [Brain metastases in cases of renal cell carcinoma].

Authors:  S Buse; J Bedke; M Kurosch; A Haferkamp; A Unterberg; K Herfarth; M Hohenfellner
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

5.  Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.

Authors:  Thekla Meyners; Christine Heisterkamp; Jan-Dirk Kueter; Theo Veninga; Lukas J A Stalpers; Steven E Schild; Dirk Rades
Journal:  BMC Cancer       Date:  2010-10-26       Impact factor: 4.430

Review 6.  Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview.

Authors:  Valeria Internò; Pierluigi De Santis; Luigia Stefania Stucci; Roberta Rudà; Marco Tucci; Riccardo Soffietti; Camillo Porta
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

7.  Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection.

Authors:  Franziska M Ippen; Anand Mahadevan; Eric T Wong; Erik J Uhlmann; Soma Sengupta; Ekkehard M Kasper
Journal:  J Oncol       Date:  2015-11-19       Impact factor: 4.375

8.  Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.

Authors:  Shelly Lwu; Pablo Goetz; Eric Monsalves; Mandana Aryaee; Julius Ebinu; Norm Laperriere; Cynthia Menard; Caroline Chung; Barbara-Ann Millar; Abhaya V Kulkarni; Mark Bernstein; Gelareh Zadeh
Journal:  Oncol Rep       Date:  2012-11-14       Impact factor: 3.906

Review 9.  The Role of Surgery in Spinal Intradural Metastases from Renal Cell Carcinoma: A Literature Review.

Authors:  Sergio Corvino; Giuseppe Mariniello; Domenico Solari; Jacopo Berardinelli; Francesco Maiuri
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.